Consumers and health professionals are advised that GlaxoSmithKline Consumer Healthcare Australia, in consultation with the TGA, is in the process of recalling three batches of Children’s Panadol 5-12 Years, supplied in 200ml bottles.
The TGA said an ingredient used in the manufacture of these medicines may have been contaminated with small particles that could contain trace minerals and inert fibres. The quantity of these particles would be small and may not be visible in the product.
According to the TGA, there is a very low risk of allergic reaction and, potentially, the medicine may be less effective over time.
The affected batch numbers are:
- 136418 (strawberry flavour).
- 136444 (strawberry flavour).
- 136443 (orange flavour).
The expiry date for each of the recalled products is February 2018.
Pharmacists are instructed to inspect their stock to see if they have any Children’s Panadol 5-12 Years from the batch numbers mentioned. If so, they should quarantine these products and arrange for their return in accordance with the recall procedures, the TGA said.
If treating a patient who uses Children’s Panadol 5-12 Years, the TGA advises that pharmacists should inform the child’s parent or carer of this issue and ask them to check the bottle label and/or the base of the outer box to determine if it is from the batch numbers mentioned.
The TGA adds that if they have a bottle from one of the affected batches, patients should be advised not to use it and to return it to the place of purchase for a refund,
Those with questions or concerns about this issue should call GlaxoSmithKline Consumer Healthcare Australia on 1800 251 905.